Advancements have been made in the pain management field that have successfully found FDA approved alternatives to ...

Sen. Mark Kelly champions the PAIN Act to improve seniors' access to non-opioid pain treatments under Medicare.

Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...

Ben Hargreaves finds that a new line of attack could be the development of more effective non-opioid painkillers, with one potential therapy moving closer to approval. The opioid epidemic in the ...

The hope is that a new generation of non-opioid analgesics will become available to treat both acute and chronic pain and have a reduced risk of addiction. In 2023, more than 100,000 lives were ...

We recently compiled a list of the 12 Best Small Cap Pharma Stocks to Buy Now. In this article, we are going to take a look ...

Advances Pacira’s “5x30” path to becoming an innovative biopharmaceutical organization -- -- Adds novel, high-capacity, local ...

Leaders with Project Opioid, a non-profit established after the opioid epidemic was declared a public health emergency in 2017, said the trend of declining overdose deaths is encouraging, but there is ...

BTB Therapeutics, Inc., a clinical-stage drug development company developing a non-opioid pain medicine ENDOPIN, today announced the election of David R. Snyder, Esq. and Nobuhiro Yagi, PhD to its ...

Behind pharmacy counters across Arkansas, pharmacists serve as the link between health-care providers and patients managing pain. While they work diligently to ensure safe medication use and counsel ...

The one-size-fits-all approach to pain management should be a thing of the past. But we’re still not there yet.